Crossmark

Correction: Capmatinib for the treatment of METex14 skipping non-small cell lung cancer: retrospective analysis of real-world data from patients receiving compassionate use treatment in Italy

Crossref DOI link: https://doi.org/10.1007/s10238-025-01988-2

Published Online: 2025-12-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cecere, Fabiana Letizia

D’Argento, Ettore https://orcid.org/0000-0001-8802-9876
Gelsomino, Francesco https://orcid.org/0000-0002-9204-1728
Pesola, Francesco https://orcid.org/0000-0001-7735-8973
Bironzo, Paolo https://orcid.org/0000-0002-2784-5076
Grisanti, Salvatore https://orcid.org/0000-0001-6922-1934
Bonanno, Laura https://orcid.org/0000-0001-5218-4970
Spitaleri, Gianluca https://orcid.org/0000-0003-3742-9962
Valsecchi, Diletta https://orcid.org/0009-0009-3268-0876
Marcon, Ilaria https://orcid.org/0009-0001-1363-899X
Cortinovis, Diego https://orcid.org/0000-0001-7611-7369
License Information

Text and Data Mining valid from 2025-12-18

Version of Record valid from 2025-12-18
More Information

Article History

First Online: 18 December 2025